Buscato, Reynamae -.
HRN: 26-84-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/27/2025
04/02/2025
IVT
2.25gm
Q8
7days
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes